Advances in Food-Induced Anaphylaxis

被引：0
作者：
Badellino H. [1 ]
Jares E. [2 ,3 ]
机构：
[1] Respiratory Medicine Department, Clínica Regional del Este, Corrientes, 291, San Francisco
[2] CMP SA, Ramos Mejía, Buenos Aires, Provincia de Buenos Aires
[3] Fundación LIBRA, Lavalle
来源：
Current Treatment Options in Allergy | 2016年 / 3卷 / 3期
关键词：
Adrenaline; Anaphylaxis; Auto-injector; Epinephrine; Food allergy;
D O I：
10.1007/s40521-016-0093-1
中图分类号：
学科分类号：
摘要：
Anaphylaxis is a potentially life-threatening severe systemic reaction and food allergy is one of its most frequent causes. Diagnosis of food-induced anaphylaxis requires diagnostic criteria for anaphylaxis based on clinical features and a comprehensive history. Adrenaline is a first-line treatment along with support measures. Epinephrine (adrenaline) is the first choice drug in anaphylaxis because it is the only medication that has been proved to reduce hospitalization and death. Long-term treatment based on an accurate identification of the anaphylaxis trigger, a clear education and training of the patients, their family and the community, under the coordination of a trained allergist, is strongly recommended in order to avoid future events. © 2016, Springer International Publishing AG.
引用
收藏
页码：224 / 234
页数：10
相关论文
共 44 条
  • [1] Simons E., Ardusso L., Bilo M., Cardona V., Ebisawa M., El-Gamal Y.M., Et al., International consensus on (ICON) anaphylaxis, World Allergy Organ J, 7, (2014)
  • [2] Sharma H., Bansil S., Uygungil B., Food allergy and food-induced anaphylaxis, Pediatr Clin N Am, 62, pp. 1377-1392, (2015)
  • [3] Moneret-Vautrin D.A., Morisset M., Flabbee J., Beaudouin E., Kanny G., Epidemiology of life-threatening and lethal anaphylaxis: a review, Allergy, 60, pp. 443-451, (2005)
  • [4] Techapornroong M., Akrawinthawong K., Cheungpasitporn W., Ruxrungtham K., Anaphylaxis: a ten years inpatient retrospective study, Asian Pac J Allergy Immunol, 28, pp. 262-269, (2010)
  • [5] Wood R.A., Camargo C.A., Lieberman P., Sampson H.A., Schwartz L.B., Zitt M., Collins C., Tringale M., Wilkinson M., Boyle J., FEL S., Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States, J Allergy Clin Immunol, 133, pp. 461-467, (2014)
  • [6] Decker W.W., Campbell R.L., Manivannan V., Luke A., St Sauver J.L., Weaver A., Et al., The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project, J Allergy Clin Immunol, 122, pp. 1161-1165, (2008)
  • [7] Poulos L.M., Waters A.M., Correl P.K., Loblay R.H., Marks G.B., Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005, J Allergy Clin Immunol, 120, pp. 878-884, (2007)
  • [8] Gupta R., Sheikh A., Strachan D.P., Anderson H.R., Time trends in allergic disorders in the UK, Thorax, 62, pp. 91-96, (2007)
  • [9] Clark S., Espinola J.A., Rudders S.A., Et al., Favorable trends in the frequency of U.S.emergency department visits for food allergy, 2001–2009, Allergy Asthma Proc, 34, pp. 439-445, (2013)
  • [10] Mulla Z., Lin R., Simon M., Perspectives on anaphylaxis epidemiology in the United States with new data and analyses, Curr Allergy Asthma Rep, 11, pp. 37-44, (2011)
12345